Sicad, Analuna I.
HRN: 01-28-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/02/2025
04/09/2025
IV
Q8
500mg
T/c Acute Surgical Abdomen Prob Sec To Perforated Peptic Ulcer Disease
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes